Health
Funding will allow advancement of Nottingham COVID-19 vaccine to clinical trials – Mirage News
Scientists at the University of Nottingham and Nottingham Trent University are to begin clinical trials for a DNA vaccine to prevent COVID-19. Experts…
Scientists at the University of Nottingham and Nottingham Trent University are to begin clinical trials for a DNA vaccine to prevent COVID-19.
Experts from both universities are working with Scancell Holdings plc, a developer of novel immunotherapies for the treatment of cancer, to adapt its existing cancer vaccine platform for the development of a new vaccine.
Now, thanks to funding from Innovate UK, as part of UK Research and Innovation’s response to COVID-19, work can progress to Phase I cl…
-
Business11 hours ago1 ASX dividend stock down 43% I’d buy right now
-
General21 hours agoCoalition abandons ‘end’ to work from home, walks back 41,000 job cuts
-
Noosa News11 hours agoBanana farmers still salvaging fruit four weeks after ex-Tropical Cyclone Alfred
-
Business14 hours ago5 things to watch on the ASX 200 on Monday 7 April 2025